- Issuer ticker
-
CYTK
- Reported as of
-
15 May 2024
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
16 May 2024, 18:06:20 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ John Faurescu, attorney-in-fact for Mr. Costa
Key filing fact
Santo J. Costa filed Form 4 for CYTOKINETICS INC (CYTK) on 16 May 2024.
Key facts
- This page summarizes Santo J. Costa's Form 4 filing for CYTOKINETICS INC (CYTK).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 May 2024, 18:06.
Change
- Previous filing in this sequence was filed on 23 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYTK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,600
- Change %
- +37%
- Price
-
$0.000000
- Shares after
- 20,600
- Date
- 15 May 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYTK
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +3,636
- Change %
- Price
-
$0.000000
- Shares after
- 3,636
- Date
- 15 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,636
- Exercise price
- $60.50
* marks a reported price that did not pass the local price check.